R

ResMed Inc. (RMD)

NYQ – Real vaqt narxi. Valyuta: USD

203.79

+5.03 (2.53%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

R

ResMed Inc. (RMD)

NYQ – Real vaqt narxi. Valyuta: USD

203.79

+5.03 (2.53%)

Yopilishda: May 12, 2026, 4:00 PM EDT

09.05.2026

10 Dividend Growth Stocks: May 2025

Dividend growth stocks have a streak of at least 5 consecutive years of dividend increases. I rank a selection of dividend growth stocks and present the top 10 stocks for consideration. To rank stocks, I do a quality assessment and sort candidates by quality scores. My new quality scoring system rates dividend stocks on a 10-point scale across 9 weighted factors. Each factor blends qualitative signals and quantitative metrics.

05.05.2026

Here's Why ResMed (RMD) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

01.05.2026

RMD Stock Down Despite Q3 Earnings & Revenue Beat, Margins Rise

Resmed beats Q3 earnings and revenue estimates with strong margin gains, yet shares slip post earnings despite growth across key segments.

01.05.2026

ResMed Inc. (RMD) Q3 2026 Earnings Call Transcript

29.04.2026

Wall Street's Insights Into Key Metrics Ahead of ResMed (RMD) Q3 Earnings

Besides Wall Street's top-and-bottom-line estimates for ResMed (RMD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2026.

23.04.2026

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

ResMed (RMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

23.04.2026

Resmed's Q3 Earnings on Deck: What's in Store for the Stock?

RMD gears up for fiscal Q3 earnings with steady estimates, rising demand in sleep devices and AI-driven digital health tools poised to shape results.

Videolar

No Data

There is no data to display

Press-relizlar

03.03.2026

Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains 53% of people surveyed rank sleep as the most important behavior for a long, healthy life, ahead of diet and exercise. Over half of respondents get quality sleep on only four nights a week or less.

24.02.2026

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, is opening a new distribution center in Greenwood, Indiana. Scheduled to begin operations in 2027, the center will expand Resmed's U.S. presence and strengthen the company's distribution capacity to better serve patients and providers across North America.

29.01.2026

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026

Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com

18.12.2025

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, beginning at approximately 10:30 a.m. (Pacific Standard Time) in San Francisco, CA.

Search stocks

ResMed Inc. (RMD)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

ResMed Inc. (RMD)

10 Dividend Growth Stocks: May 2025

Here's Why ResMed (RMD) is a Strong Growth Stock

RMD Stock Down Despite Q3 Earnings & Revenue Beat, Margins Rise

ResMed Inc. (RMD) Q3 2026 Earnings Call Transcript

Wall Street's Insights Into Key Metrics Ahead of ResMed (RMD) Q3 Earnings

ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth

Resmed's Q3 Earnings on Deck: What's in Store for the Stock?

Videolar

No Data

Press-relizlar

Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference